Raphael Dolin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Raphael Dolin has a total of 444 co-authors. Here are the top co-authors by number of shared publications:
Ayush Giri
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center Boston, Massachusetts
2 shared publicationsColleen Devoy
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center Boston, Massachusetts
2 shared publicationsHaesook T. Kim
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute Boston, Massachusetts
2 shared publicationsJane A. Kleinjan
Division of Infectious Diseases, Brigham and Women's Hospital Boston, Massachusetts
2 shared publicationsKristen E. Stevenson
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute Boston, Massachusetts
2 shared publicationsLauren E. Grandpre
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center Boston, Massachusetts
2 shared publications
Latest Publications
- Open Access
- 11 July 2013
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 208 (4) , 539-540
The Quadrivalent Approach to Influenza Vaccination
(See the major article by Langley et al on pages 544–53.)
- 11 July 2013
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 208 (4) , 539-540
Open AccessThe Quadrivalent Approach to Influenza Vaccination
(See the major article by Langley et al on pages 544–53.)
- Open Access
- 1 May 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (9) , 1361-1370
Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration
(See the article by Seaman et al, on pages 1353–1360.)Background. We conducted a clinical trial of the safety and immunogenicity of modified vaccinia
- 1 May 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (9) , 1361-1370
Open AccessSafety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration
(See the article by Seaman et al, on pages 1353–1360.)Background. We conducted a clinical trial of the safety and immunogenicity of modified vaccinia
- Open Access
- 1 May 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (9) , 1353-1360
Effect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with Dryvax
(See the article by Wilck et al, on pages 1361–1370.)Background. Despite the success of smallpox vaccination, the immunological correlates of protect
- 1 May 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (9) , 1353-1360
Open AccessEffect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with Dryvax
(See the article by Wilck et al, on pages 1361–1370.)Background. Despite the success of smallpox vaccination, the immunological correlates of protect
- 1 January 2010
- Published by Elsevier
CONTRIBUTORS
- 1 January 2010
- Published by Elsevier
- p. 1887-1895
Vaccines for Human Immunodeficiency Virus-1 Infection
- 1 January 2010
- Published by Elsevier
- p. 1887-1895
Vaccines for Human Immunodeficiency Virus-1 Infection